1 not yet recruiting, 1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Immunochemotherapy combined with antiangiogenic: new trials by email Literature Review of Immunochemotherapy combined with antiangiogenic trials Research Report on Immunochemotherapy combined with antiangiogenic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunophenotype of PBMC to Early Predict Response to Immunotherapy in Hepatocellular Carcinoma Immunochemotherapy combined with antiangiogenic - Liver Cancer, Adult | Recruiting | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 100 | 2024-09-15 | 2025-01-16 | |
| Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC Immunochemotherapy combined with antiangiogenic, Immunochemotherapy - Non-Small Cell Lung Cancer, Anti Angiogenesis | Phase 2 | Not yet recruiting | Tang-Du Hospital | 178 | 2024-06-30 | 2024-06-26 |
Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · Tang-Du Hospital (1)
China (1) · Italy (1)
Laura Gramantieri (1) · Linna Liu (1)